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According to the World Health Organization, 31% of all deaths worldwide result from 
cardiovascular diseases (CVDs), mostly in low- and middle-income countries. Even though 
Russia, an upper-middle income country, still have higher CVD mortality compared to the 
neighboring countries such as Finland and Norway, it has seen a reduction in CVD mortality 
since the turn of the millennium. Investigating how risk factors have changed over the years 
might be beneficial to the explanation of the recent downward of CVD mortality in Russia. 
Objectives: 
The objective of this thesis was to see if there have been any changes in the classical 
risk factors of CVDs since the year 2000 in a north-western city of Arkhangelsk in Russia. 
Subjects & Methods: 
 A cross-sectional study on CVDs called Arkhangelsk study 2000 (Ark.2000) was 
performed in Arkhangelsk in 2000. 15 years later, another cross-sectional study called Know 
Your Heart (KYH) was carried out in Arkhangelsk and Novosibirsk as a part of the International 
Project on Cardiovascular Disease in Russia (IPCDR). Changes in the classical CVD risk 
factors since 2000 were investigated by descriptive statistics by comparing these two studies. 
 For the comparison purpose, participants above 40 years of age were included for the 
analyses in this thesis. 2132 participants (1087 men) from Ark.2000, recruited at a polyclinic 
while attending annual health checks, and 2222 participants (930 men) from the Arkhangelsk 
part of KYH, randomly selected from the general population, were included. Raw data was 
available from KYH, but not from Ark.2000. Therefore, descriptive statistics published from 
Ark.2000 and raw data from KYH were used for the comparison. Some of the classical risk 
factors that were comparable between the studies were included. Those were total and high-
density lipoprotein (HDL) cholesterol, systolic and diastolic blood pressures (BPs), resting 
 
 
heart rates (RHRs), body mass index (BMI), education, physical activity at work, smoking, 
alcohol consumption measured by gamma-glutamyl transferase (GGT), Alcohol Use Disorder 
Identification Test (AUDIT), and the CAGE questionnaire (CAGE). Using those risk factors, 
Ten-year risk of developing coronary heart disease (CHD) was calculated by Framingham risk 
scores. 
Results: 
For men, total and HDL-cholesterol, systolic BP, GGT, AUDIT, and smoking have 
improved while diastolic BP, RHR, BMI, physical activity at work, and CAGE have shown 
opposite trends. Although most of the variables related to alcohol such as GGT and AUDIT 
decreased, GGT remained still high in all age groups (40-49, 50-59, above 60). Improvements 
in some of the risk factors improved the risk scores for developing CHD for ages above 60. 
For women, total and HDL-cholesterol, systolic BP, GGT, AUDIT, CAGE, education, 
and physical activity at work have shown improvements. However, diastolic BP, RHR, and 
smoking showed unfavorable trends, and BMI remained similar over the years. Improvements 
in ten-year risk scores for developing CHD were seen in all age groups, and they were lower 
for women compared to men. 
Conclusion:  
Some of the classical risk factors have shown improvements over the years for both men 
and women, which has led to improvements in the ten-year risk scores of CHD development. 
However, those changes are still small, and the factors which have not been improved may be 
hindering a further reduction in CVD prevalence. For further reduction in risk factors, control 
of alcohol consumption for men and BMI and smoking for women would be necessary. In order 
to understand the reasons behind the recent reduction in CVD mortality in Russia, conducting 
longitudinal studies will be important. In addition, communicating the results of the studies to 
the general public in Arkhangelsk would be beneficial for the prevention of CVDs.      
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1 Introduction & Background 
1.1 CVDs Worldwide 
According to the World Health Organization (WHO), 17.9 million people worldwide died 
from cardiovascular diseases (CVDs) in 2016 (1). This is 31.4 percent (%) of all deaths in the 
world (2). Figure 1 shows the top five causes of deaths worldwide between 2000 and 2016 (2,3) 
Two of the highest global cause of deaths are ischemic heart disease and stroke, which account 
for 26.8%, 15.2 million, of deaths in 2016 globally (2,3). These two diseases account for 85% 
of the CVD deaths, and more than 80% of the world’s CVDs occur in low- and middle-income 
countries (1) 
Figure 1: Top five global causes of deaths                   Source: (2) 
 
1.2 CVDs in Russia 
1.2.1 Life Expectancy and CVDs in Russia, Comparison with the 
Neighboring Countries 
Although the life expectancy at birth (LE) including both men and women in Russia has 
been increasing since 2003, it had fluctuated between the 1970s and 2000s (4). With the decline 
in the number of deaths from infectious diseases, the LE including both genders in the former 
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Soviet Union in the 1960s were similar to Finland and Japan (4–7). Figure 2 shows the LE 
including both genders in four countries between 1960 and 2015 (4,6–8).  
Figure 2: Life expectancies at birth: Russia, Finland, Norway, and Japan 1960-2015
                                      Source (4,6–8) 
 
Improvements in the LE were shown in the former Soviet Union until 1970; however, 
inadequate response to the epidemiological transition from infectious diseases to non-
communicable diseases (NCDs) such as CVDs started to affect the LE in the 1970s (5). The LE 
improved during the 1980s from Gorbachev’s anti-alcohol campaign; however, the removal of 
all restrictions on the alcohol sales and the stress from political and socioeconomic transitions 
including the financial crisis in Russia during the 1990s increased CVD deaths and lowered life 
expectancies at birth (5,9,10). The difference in the total life expectancy at birth between Russia 
and the average of the other three countries was 13.6 years in 2000 (4,6–8). Since 2000, CVDs 
remain to be the leading causes of mortality and account for more than half of deaths in Russia 
(11). Table 1 shows the percent of total deaths due to CVDs between 2000 and 2016 for Russia, 
Finland, Norway, and Japan (2). Even though the amount of CVD deaths is declining in Russia 
since 2010, the rate of declining is slow compared to those other countries. The amounts of 
66,1
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CVD deaths between 2000 and 2016 have decreased by 13.6%, 7.3%, and 3.5% in Norway, 
Finland, and Japan, respectively (2).  However, it was only 0.6% for Russia (2). CVD deaths 
still account for more than half of all-cause deaths, 54.7%, as of 2016. The difference in the LE 
between Russia and the average of those three countries is still 11.3 years in 2015 (4,6–8). 
Improvements in CVD mortality might improve life expectancy further in Russia. According 
to the 2004 World Bank report, matching the European Union’s CVD mortality rate would 
enable Russia to gain 6.7 years in life expectancy (10). 
Table 1: The percent of total deaths due to 
CVDs in Russia, Finland, Norway, and 
Japan 
Source: (2) 
Russia experiences not only high CVD mortality but also lower healthy life expectancy 
(HALE). HALE takes into account mortality and morbidity, adjusted based on the severity of 
illnesses and considered to be the length of a life lived without disability (10). According to the 
WHO, the HALE at birth was 63.3 years worldwide in 2016 (12). Table 2 shows the HALE at 
birth in Russia, Finland, Norway, and Japan in 2016. Although the HALE at birth in Russia was 
above the global average in 2016, differences in HALE at birth between Russia and the average 
of the three countries were 9.6 years (13).  
Table 2: HALE at birth in Russia, Finland, Norway, and Japan in 2016 Source: (13) 
 Russia Finland Norway Japan 
HALE at birth in 2016 (years old) 63.5 71.7 73.0 74.8 
Comparing to the countries such as Finland, Norway, and Japan, Russia has both lower 
LE and HALE due to the strong influence of NCD mortality and morbidity including CVDs 
(10).  
 Russia Finland Norway Japan 
2000 55.3% 43.1% 42.0% 30.9% 
2010 56.2% 40.0% 32.5% 29.0 % 
2015 54.7% 37.0% 29.2% 27.6% 
2016 54.7% 35.8% 28.4% 27.4% 
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1.2.2 Comparison between Russia and European Countries with Lower 
GDP per capita than Russia  
Based on the gross domestic product (GDP) per capita data provided by the World Bank, 
15 countries in Europe had a lower GDP per capita than Russia in 2016 (14). Table 3 shows the 
GDP per capita (constant 2010 US $), the LE, and age-adjusted CVD mortality rates of some 
of the countries. The age-adjustment was performed using the European standard population of 
2013 (15). 
Table 3: GDP per capita, LE, age-adjusted CVD mortality rates of Russia and some 
European countries with lower income than that of Russia 
 GDP per capita 
(constant 2010 US$) 
LE (years 
old) 
Age-Adjusted CVD Mortality Rate 
(per 100,000 population) 
Russia 11,279.6 71.6 957.9 
Romania 10,236.9 75.0 835.3 
Bulgaria 7,966.9 74.6 949.0 
Montenegro 7,487.4 77.1 829.8 
Albania 4,683.5 78.3 757.5 
Kosovo 3,925.3 71.6 - 
Ukraine 2,909.6 71.5 1075.0 
Moldova 2,070.6 71.6 - 
Source: (2,14,15) 
Of those European countries, Ukraine was the only country that had a lower LE and a 
higher age-adjusted CVD mortality than Russia, 71.5 and 71.6 years and 1075.0 and 957.9 per 
100,000 population, respectively (14). The highest LE was of Albania, 78.3 years (14). There 
were two European Union countries with lower GDP per capita than Russia: Romania and 
Bulgaria. Both of them had a higher LE than Russia, 75.0 and 74.6 years, respectively (14). For 
the age-adjusted CVD mortality rates, all the countries except Ukraine had a lower rate than 
Russia (2,15). These results suggest that the LEs and the age-adjusted CVD mortality rates are 
not solely dependent on the GDP per capita (5). The recent study by Shkolnikov et al. 
discovered high mortality from external causes for working ages and from CVDs for older ages 
when comparing Russia with countries with similar GDP per capita (16).  
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1.2.3 Health Expenditure Trend and Cost of CVDs in Russia  
Russian public expenditures on health have fluctuated over the years, similar to its LE. 
Figure 3 shows the percentage of GDP that current health expenditure of Russia accounts for 
since 2000 (17). 
Figure 3: Health expenditure of Russia 2000-2016     Source: (17) 
     
Although the global trends in health expenditure show an increase in public sources and 
a decrease in out-of-pocket payments, public spending on health has been decreasing since 2014 
in Russia and out-of-pocket payments have been increasing since 2012 (17,18). In 2016, Russia 
spent 5.26% of GDP for total health expenditure with 3.00% as public spending and 2.13% as 
out-of-pocket, suggesting roughly 40% of health expenditure comes from out-of-pocket, 
making it hard to access healthcare for people with lower socioeconomic status (17).  
Of the health expenditure, CVDs were estimated to cost RUB 836.1 billion (€24,517.8 
million) in 2006 and RUB 1076 billion (€24,400.4 million) in 2009, including both direct 
(healthcare costs) and indirect costs (non-healthcare costs) (19). Those amounts were estimated 
to account 3.1% and 2.8% of GDPs in 2006 and 2009, respectively (19). Since the total 
healthcare expenditure of Russia was 4.74% of GDP in 2006 and 5.61% of GDP in 2009, 65.4% 
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controlling hypertension by antihypertensive treatment can significantly reduce CVD mortality, 
diagnoses, and CVD healthcare costs (20). Comparing to the current rate, achieving 40% and 
60% of systolic blood pressure (BP) control rates were estimated to reduce 1.0 million and 2.4 
million 10-year total number of CVD deaths, 1.2 million and 2.7 million stroke or myocardial 
infarction (MI) diagnoses, and US$1.1billion and US$2.6 billion direct costs, respectively (20). 
It was also estimated that achieving these hypertension control rates would increase 1.21 and 
2.72 years of LE in the working-age population, respectively (20).  
1.2.4 CVD trends in Russia since 2000 and Disparities within the Country 
With the increase in the LE, CVD mortality has been declining since 2000 in Russia. 
Table 4 shows the estimated population and the number of CVD deaths by WHO for 2000, 
2010, 2015, and 2016.   
















2000 146,397 1246.5 68,509 547.6 77,887 698.8 
2010 143,154 1142.8 66,389 511.1 76,765 631.7 
2015 143,888 1027.0 66,848 451.3 77,040 575.7 
2016 143,965 1022.8 66,899 448.1 77,066 574.7 
Source: (2) 
Both male and female CVD deaths have decreased, which lead to a reduction in total 
CVD mortality (2). Between 2000 and 2016, the total CVD deaths have fallen from 1246,500 
to 1022,800 with the reduction rate of 17.9% (2). During the same period, CVD deaths 
decreased from 547,600 to 448,100 with 18.2% reduction rate for male and from 698,800 to 
574,700 with 17.8% reduction for female (2). 
Although the reduction rates for the total, male, and female population seem similar, 
there are disparities in CVD mortality rates between genders. Age-specific CVD mortality rates 
and age-adjusted CVD mortality rates for the total population, male, and female are shown in 
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table 5. For age-adjusted CVD mortality rates, the European Standard Population of 2013 was 
used for the calculation (15). 
Although age-specific CVD mortality rates for the age 0-4 and 5-14 are similar between 
genders, the difference in CVD mortality becomes larger starting at age 15. Especially the 
groups that are in the working-age, 15 to 64 years of age, male CVD mortality rates were 2.8-
4.0 times higher than those of female (2,15). Furthermore, age-adjusted CVD mortality rates 
were 957.9, 1165.4, and 826. 5 per 100,000 population for total, male, and female, respectively 
(2,15). These results show higher male CVD mortality is raising the total CVD mortality rates. 
These differences in CVD mortality between male and female correspond with the differences 
in the LEs, 66.5 and 76.9 years for male and female, respectively (21,22). Some studies suggest 
that the differences in CVD mortality between genders can be explained by psychological and 
behavioral factors: gender differences in care-seeking, alcohol consumption, smoking, 
educational levels, and socioeconomic status (10). 
Table 5: Age-specific CVD mortality rates and age-adjusted CVD mortality rates (per 
100,000 population) in Russia in 2016                              Source: (2,15)  
 Age-Specific CVD Mortality Rates                
(per 100,000 population) 
Age Total Male Female 
0-4 1.17 1.27 1.07 
5-14 0.54 0.55 0.52 
15-29 12.8 18.8 6.45 
30-49 104.5 169.2 42.3 
50-59 413.6 690.1 185.0 
60-69 987.6 1598.6 568.5 
70+ 5410.3 5988.5 5166.4 
Age-Adjusted CVD Mortality Rates 
(per 100,000 population) 
957.9 1165.4 826.5 
Another disparity in mortality and LEs can be seen among different regions due to 
socioeconomic and health level differences (10). Mortality rates of economically active male 
population ranged from 3.8 to 17.8 deaths per 100,000 population among regions (10). Alcohol 
consumption also differs among regions with higher consumption and mortality in rural areas 
(10). Reduction in coronary heart disease (CHD) mortality rates between 2005 and 2013 were 
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different among regions: Moscow with the highest reduction, 1.3 times higher than that of St. 
Petersburg, 2.6 times higher than in the Moscow region, and 1.5 times higher than the country 
as a whole (23). The highest CVD mortality rates in 2009 were found in the Northwest regions 
of the country such as Tver and Pskov regions while the lowest CVD mortality was seen in the 
Southern Federal District such as Chechnya and Ingushetia (5). Between 2012 and 2016, the 
total circulatory disease mortality for 35-69 years old in urban Novosibirsk region was lower 
than that of the national average while that was higher for the urban Arkhangelsk region (24).  
1.2.5 Preventive Interventions in Russia 
Although the CVD mortality in Russia is still high, the government has started programs 
to prioritize health. “Prevention and Treatment of Arterial Hypertension in the Russian 
Federation” between 2002 and 2008 had focused on one of the CVD risk factors, hypertension 
(10). “National Priority Project Health” started in 2005 increased availability of modern 
treatments and interventions for CVDs with special focus on primary prevention of CVDs 
(23,25). Multidisciplinary and inter-sectorial document “Strategy for Prevention and Control 
of Non-communicable Diseases and Injuries in the Russian Federation” was also developed in 
2008 by focusing on policy development, health care systems, personnel training, public 
education, risk factor monitoring systems, and international cooperation (5). In 2013, the 
program “Dispanserization” started to improve screening as well as risk factor counseling and 
management (23,25).  
1.3 Risk Factors of CVDs 
O’Donnell defines risk factors as “a measurable element or characteristic that is causally 
associated with an increased rate of a disease and that is an independent and significant 
predictor of the risk of presenting a disease” (26). Risk factors of CVDs can be categorized into 
non-modifiable risk factors and modifiable risk factors. Non-modifiable risk factors include 
age, gender, and family history of CVDs (27). Modifiable risk factors include a raised level of 
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blood cholesterol and triglycerides, low-density lipoprotein (LDL)-cholesterol, high-density 
lipoprotein (HDL)-cholesterol, high BP, diabetes, smoking, unhealthy diet, obesity and 
overweight, physical inactivity, and an excessive amount of alcohol, socioeconomic factors, 
and stress (1,27). For alcohol use, the Alcohol Use Disorder Identification Test (AUDIT) and 
the CAGE questionnaire (CAGE) are used to identify hazardous alcohol consumption patterns. 
AUDIT has 10 questions including three sections to identify hazardous use, dependence, and 
harmful use (28). The cutoff points are eight for AUDIT and two for CAGE with a total of four 
questions for CAGE (28,29).  
These classical risk factors have been studied extensively through Framingham Heart 
Study since 1948 (26).  In 1957, high BP and cholesterol levels were found to increase the risk 
of heart disease (26).  In the 1960s, the association between smoking and heart diseases was 
found followed by the association between heart diseases and sedentary lifestyles including 
obesity (26). Since 1970, more CVD risk factors and underlying diseases have been identified 
through the study: high BP and risk of stroke in 1970, diabetes with CVDs in 1974, triglycerides 
and lipoproteins with heart diseases in 1977, atrial fibrillation with stroke in 1978 (26). In the 
1980s, the direct association of isolated systolic BP and heart diseases was found while HDL-
cholesterol was found to be inversely associated with mortality (26). In the 1990s, risk factors 
of atrial fibrillation were described followed by the description of the progression of 
hypertension to heart failure and the development of the new method of predicting coronary 
disease risk (26).   
1.3.1 Changes in Risk Factors in Other Countries 
Some of the levels of these risk factors have declined over the years and have 
contributed to the decline of CVDs in the western world. In the United States, the Framingham 
Heart Study showed a lower serum cholesterol level, a lower systolic BP, reduced level of 
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cigarette smoking, and better management of hypertension contributing to the decline in CVDs 
(30).  
Due to its geographical location close to northern Russia, CVD researches from northern 
Norway are worth mentioning. In northern Norway, more than 40 years of cardiovascular 
research through the Tromsø Studies between 1974 and 2016 showed a reduction in total 
cholesterol, BP, and smoking corresponded to reduced CHD deaths (31). The mean total 
cholesterol decreased between 1979 and 2016 in both men and women in all age groups (32) 
Total cholesterol increased with age with a peak around middle age followed by a decline, and 
total cholesterol declined based on age: the younger, the lower (32). Lipid-lowering drug 
treatment for above 50 years old was associated with 21% and 28% of total cholesterol decline 
in women and men, respectively (32). Moreover, the Tromsø Studies showed that the decline 
in mean systolic and diastolic BPs from 1979 to 2008 in both genders for the ages of 30 to 89 
years (33). The decrease in systolic BP for the age group of 40 to 49 years was more than twice 
as high in women compared to men (33). Systolic BP increased in both genders born between 
1920 and 1949, but younger participants had a decrease or flattening of the curve (33). For 
ischemic stroke, systolic BP accounted for 26% of the decline (34). The reduced level of 
smoking in the same study accounted for 17% of the decline in ischemic stroke (34). In addition, 
the reduction in resting heart rates (RHR) has attributed to favorable changes in other risk 
factors of CVDs in the Tromsø Studies especially for those participants whose BP, total and 
HDL-cholesterol, triglycerides, body mass index (BMI), smoking, and physical activity 
changed from adverse to favorable values and those who started BP treatment (35,36) 
The Tromsø Studies also showed a 3.0 % decline in acute CHD between 1994 and 2010, 
and the changes in CHD risk factors accounted for 66% of the decline (37). The severity and 
the case fatality rates of MIs declined in both genders; however, the age-adjusted incidence of 
MIs in the age group 35-79 showed a decline in men but an increase in women (38). 
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1.3.2 Risk Factors of CVDs in Russia 
Some of the classical risk factors seem to attribute significantly to CVDs in Russia. The 
important factors include high alcohol intake, smoking, eating habits, hypertension, physical 
inactivity and obesity, psychological stress, and dyslipidemia (5). However, special attention 
should be given to alcohol, smoking, hypertension, and obesity due to the high prevalence of 
these risk factors in Russia.  
Alcohol consumption remains high for the past few decades in Russia, 10-15 liters per 
person per year (5). Current alcohol consumption in Russia is 11.7 liters; however, it is still 
higher compared to the neighboring countries such as Norway and Finland, 7.5 and 10.7 liters 
per person per year according to WHO World Health Statistics 2018 (39). In 2004, 70% of men, 
47% of women, 30% of teenagers consumed alcohol with 70% of the population preferred 
drinking strong alcoholic beverages (5,10). For Karelia population in Pitkäranta region of 
Russia, a study using biomarkers indicated alcohol abuse (>20g/day) in 37% of men and 18% 
of women (5). These values were more than twice as high compared to those in Finland, 9.6% 
for men and 9.4% for women (5). Some studies suggested that 21.4% of CVD deaths in Russia 
were attributed to alcohol, and one-liter increase in per capita consumption showed an increase 
in CHD mortality: 3.6% in male and 4.5% in age 30-54 (9). This relationship of an increase in 
alcohol consumption and an increase in mortality was found for CHD, stroke, and hypertension 
as well: 41.1% of male and 30.7% female CHD deaths, 26.8% of male and 18.4% of female 
deaths from stroke, and 57.5% of male and 48.6% of female deaths due to hypertension were 
attributed to alcohol consumption (9). In the study of alcohol-related deaths, acute ischemic 
heart disease except MIs was the third highest in Russia (40). Binge drinking is found to be 
strongly associated with CVD mortality (10,41,42). 
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Tobacco smoking is also crucial.  According to WHO, the prevalence of smoking for 
men and women above 15 years of age in 2015 were 59.3 and 19.3 for Russia and 22.1 and 
21.2 for Norway, respectively (43).  There were regional differences as well.  The proportions 
of smokers were different among regions: 56-60.3% in men and 19.6-3.7% in women in 
Moscow, Tver, and St. Petersburg, according to the  Russian Longitudinal Monitoring Survey 
(RLMS) (5).  In addition, 29% of CVD deaths in Russia were found to be attributed to smoking 
(5). 
High prevalence of hypertension has been a problem in Russia as uncontrolled 
hypertension has 3-4 times higher risk of developing CHD (10). In the Izhevsk Family Study 
II between 2008 and 2009, the prevalence of hypertension and hyperlipidemia was 61 and 49%, 
respectively (44). Of those found to have hypertension, 44% were unaware of the diagnosis 
(44). Another study from Pitkäranta region of Russia found that 39% and 42% of CVDs, 41% 
and 34% of CHD, 81% and 73% of stroke were attributable to hypertension for men aged 40-
50 and women aged 30-69, respectively (5). In addition, Russian men and women with 
hypertension are estimated to live 12.2 and 6.0 years shorter than those without hypertension, 
respectively (5). 
High prevalence of overweight and obesity in Russia was estimated by WHO with 2008 
data (45). For those above 20 years of age, 56.2 and 62.8% of men and women were estimated 
to be overweight while obese was 18.6 and 32.9%, respectively (45). BMI was used to estimate 
overweight and obesity for the estimation. BMI is calculated by weight divided by the square 
of height (weight/[height]2), and overweight is defined by BMI between 25 to 29.9 while BMI 
of above 30 is considered obese (10). Diet, physical inactivity, and obesity are associated with 
elevated BP, high cholesterol levels and type two diabetes as well as a complication from type 
two diabetes causing cardiovascular problems (5,10). 
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1.3.3 Arkhangelsk Study 2000 & Know Your Heart Study 2015-2018 
Arkhangelsk study 2000 (Ark.2000) is a cross-sectional health survey combined with a 
physical examination and blood tests, held in the northwestern region of Russia, Arkhangelsk, 
between 1999-2000 to investigate the reasons behind the high CVD mortality in Russia (46). 
15 years later, another cross-sectional study called Know Your Heart study (KYH) was 
conducted in Arkhangelsk and Novosibirsk, between 2015 and 2018 as a part of the 
International Project on Cardiovascular Disease in Russia (IPCDR) (24). Although these studies 
were not designed in the same ways, some of the classical risk factors were comparable.  
2 Objectives 
The objective of this thesis is to investigate if there have been any changes in the classical 
CVD risk factors over the years by comparing data from Ark.2000 and the Arkhangelsk part of 
the KYH. The results of this comparison may add up to the explanations of the recent downward 
trends in CVD mortality in Russia.  
As CVD mortality has been falling in Russia, it would be reasonable to think that there has 
been an improvement in risk factors such as a decrease in the amount of binge drinking or 
smoking. However, many risk factors are related to human behaviors, which are difficult to 
change. Therefore, there might not be any change in risk factors of CVDs in Arkhangelsk. 
3 Methods 
3.1 Study Design & Settings 
Both Arkhangelsk Study 2000 and Know Your Heart Study 2015-2018 are cross-
sectional studies conducted in Arkhangelsk, Russia, which is an administrative center of the 
Arkhangelsk region. Arkhangelsk is located in the north of Severnaya (North) Dvina River, 40 
km from the White Sea (47). The area of Arkhangelsk is 2994.4 square kilometers (km2) with 
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a population of approximately 351,000 in 2015 and 367,000 in 1999 with 46% men and 54% 
women (47,48). In 2015, 0.24% of the total population of Russia was in Arkhangelsk (2,47). 
Arkhangelsk has a temperate climate with a long cold winter and a short cool summer (47). The 
average temperature is -12.8 degree Celsius (℃) in January and +16.3℃ in July (47). In terms 
of the economy, Arkhangelsk has historically been an important seaport, many residents 
engaged in fisheries, aquaculture, fish processing as well as dock works, shipbuilding and 
repairing (49). It is a scientific and industrial city with its major industries in woodworking, 
timber-chemical, and pulp and paper (47).  
3.2 Arkhangelsk Study 2000     
3.2.1 Recruitment of Participants 
The recruitment of participants was carried out at Semashko polyclinic, one of the 
largest polyclinics in Arkhangelsk for providing voluntary screening medical examinations of 
the general population for the purpose of prevention and early diagnosis as well as compulsory 
annual medical examinations for sailors (48). Participants who came to the clinic for annual 
medical examinations were recruited between 8:00 and noon on certain days of the week for a 
year between 1999 and 2000 (48). In addition, some of the workplaces and educational 
institutions were actively contacted and recruited for annual medical examinations such as 
students, pensioners, and teachers (48,50). Four nurses and two physicians were responsible for 
daily registration, examination, and blood tests (48). At the point of registration, attendees were 
informed about the project and asked to participate (48). 40 attendees, which is one percent of 
the attendees, refused to participate (48). The sample size was determined to be 4000 (48,50). 
In order to have participants of similar sex and age groups, recruitment of groups with enough 
participants was stopped earlier than the rest of the groups (48). 
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3.2.2 Eligibility Criteria 
All males and females aged above 18 who underwent the health check in a certain period 
were invited to participate and all of them who agreed were considered eligible for the study 
(48). The total of 4129 attendees was invited to participate, of which 40 refused to participate 
(48,50). Of 4089 who agreed to participate, 43 did not return the questionnaire and five did not 
provide blood (48,50). All the blood samples were analyzed in both Arkhangelsk and Tromsø, 
but two of serum were missing in Arkhangelsk, and three were missing in Tromsø (48,50). Of 
the 4036 participants, those younger than 18 years old were excluded from the study; hence, 
3705 attendees participated at the end (48). For the purpose of comparison in this thesis, ages 
above 40 were included (2132 participants, 1087 males and 1045 females) (50). 
3.2.3 Ethics 
At the time of the study, there were no centralized ethical committee in Russia as well 
as no ethical committee in the Arkhangelsk region (48). However, this study was approved by 
the regional ethical committee in Norway (48). In addition, verbal informed consent was 
obtained from all the participants (48). However, the use of raw data from the Arkhangelsk 
2000 was not approved for this thesis; therefore, already published data are used for the 
comparison with KYH study. 
3.2.4 Procedures: Data Collection & Examination 
There were four stages in the survey procedure: registration, questionnaire, BP and heart 
rate, and blood samples (48,50). First, information about the study was provided (48,50). For 
those agreed to participate, their names are registered, and a personal participant number was 
given (48). Anthropometrical measures such as height, weight, waist-hip circumferences were 
measured by a trained nurse (48,50). Weight measurement was performed without clothes and 
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shoes by an electronic device, which was adjusted every morning (48,50). Both height and 
weight were read to the lowest whole centimeters (cm) and kilogram (kg) (50). 
Questionnaire (See Appendix): 
At the second stage, each participant filled out a questionnaire in a separate room (48). 
The questionnaire was developed in English using the Tromsø, the Finnmark, and Svalbard 
studies, and then translated to Russian, followed by re-translation by different translators for 
quality assurance (48,50). Participants filled out a Russian version of the questionnaire, which 
has six pages, consisting of 111 questions, with the assistance of a trained nurse (48,50). The 
nurse checked if all the questionnaires were completed (48,50).  
Blood Pressure & Heart Rate: 
At the third stage, participants provided BP and heart rate measurements in another quiet 
room (48,50). Both measurements were taken three times on the right upper arm in a sitting 
position with intervals of two minutes using an automatic BP monitor (DINAMAP-R, Critikon, 
Tampa, Florida) (48,50). Both measurements were taken and recorded by a trained nurse (48). 
Blood Samples: 
At the fourth stage, participants were invited to a different room separately for blood 
sampling (48). Although participants were not told to fast for the study, most of the participants 
fasted as it was required for the annual medical examination (48,50). 25 milliliters (ml) of blood 
samples were obtained from the cubital vein by a trained nurse and centrifuged at the Semashko 
polyclinic laboratory within 15-25 minutes (48,50). On the same day, GGT and lipids were 
analyzed at the polyclinic laboratory (48,50). Four containers of serum and one container of 
full blood from each patient were frozen down to -20 degree Celsius (℃) immediately for later 
analyses (48,50). These samples were stored at -20℃ for 3-4 weeks and transported to Tromsø 
by a five-hour flight in boxes with freezing elements (48). 
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Laboratory Analyses: 
Blood analyses were performed in both Arkhangelsk and Tromsø (50). All kits 
including a new spectrophotometer were purchased in the United States and transported to 
Arkhangelsk via Tromsø (50). Due to the laboratory capacity, the spectrophotometer was 
switched back to older Kobas analyzer after two months, and all the work performed on the 
spectrophotometer were analyzed on the Kobas analyzer (50). When the results from 
Arkhangelsk and Tromsø did not agree, the results from Tromsø were used for further analyses 
(50).  
Laboratory Analyses in Tromsø:     
Enzymatic colorimetric method (cholesterol esterase and cholesterol oxidase) was used 
to analyze serum total cholesterol using a Hitachi 737 assay machine with an analytic 
coefficient of variation (CV) of five percent (48,50). Homogeneous enzymatic colorimetric test 
(PEG cholesterol esterase and PEG cholesterol oxidase) was used to analyze HDL-cholesterol 
using a Hitachi 737 assay machine with a CV of three percent (48,50). LDL-cholesterol was 
measured differently based on the serum triglyceride level (50). When triglyceride levels were 
lower than four millimoles per liter (<4mmol/l), Friedwald’s formula (LDL cholesterol = total 
cholesterol HDL cholesterol – (triglycerides * 0.46)) was used for determination of LDL-
cholesterol while the measurement of LDL-cholesterol was done directly at higher triglyceride 
levels with enzymatic colorimetric test (Roche, selective inhibition of VLDL-, chylomicron-, 
HDL-cholesterol) using a Hitachi 737 device with a three percent CV(48,50). For GGT, an 
enzymatic colorimetric assay (Roche) was used to measure the formation of free 5-amino-2-
nitrobenzoate formation, proportional to GGT activity, using Hitachi 917 device with a 2.5% 
CV(48,50).  
 
Page 18 of 59 
3.3 Know Your Heart 2015-2018 
3.3.1 Recruitment of Participants 
The sample size was calculated to be 4500 (2250 for Arkhangelsk) to have enough 
power for comparisons with other population-based studies and for investigation of associations 
of interest within KYH study (24). Four districts in Arkhangelsk (Lomonosovsky, 
Maymaksansky, Mayskaya Gorka, and Oktyabrsky) were selected for the recruitment of 
participants to represent socio-demographic and mortality range (24). Within each district, 
individuals were contacted randomly based on the age, sex, and address without individual 
names provided by the regional health insurance funds in order to have an equal number of 
participants and in each sex and each age group (five-year range) (24). Trained interviewers 
from a local commercial survey company visited the randomly selected home addresses for 
recruitment (24). An address was visited up to five times in order to reach potential participants 
at home and make the invitation (24). After successful interviews, participants were invited for 
health examination at a polyclinic with online calendar appointments upon their agreement (24). 
There was a total of 5089 participants in ages from 35 to 68 in both Arkhangelsk and 
Novosibirsk (24). Of those, the total of 4542 participants attended health check in both cities 
(24). In Arkhangelsk, there were 2381 participants with a median age of 54 with 41.5% male 
(24). The total response rate and the response rate for men and women in Arkhangelsk were 
68.2, 60.4, and 75.2% with the type three response, which includes all the addresses with people 
with expected age and sex were found (24). To see if there is any sampling bias due to non-
response, the educational distribution of the participants were compared to that of the city from 
the 2010 census after indirect standardization for age and sex (24). The overall ratio for 
completion of the questionnaire and that of attending the health examination were 0.98 and 
0.99, respectively (24).    
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3.3.2 Eligibility Criteria 
Of those participated in the baseline sociological interview (5089 participants), 4542 
participants completed health check (24). Of those who completed health check, those living in 
Arkhangelsk were 2381 (24). For the purpose of this thesis, those only above 40 years of age 
were included in the following analyses for the comparison with Ark.2000 (2222 participants 
with 930 males and 1292 females).  
3.3.3 Ethics 
Ethical approvals for the study were obtained from the ethics committees of the London 
School of Hygiene & Tropical Medicine (approval number 8808) and Northern State Medical 
University, Arkhangelsk (approval number 01/01-15) (24).  
3.3.4 Funding 
IPCDR project was funded by a Wellcome Trust Strategic Award (100217) as well as 
UiT the Arctic University of Norway, Norwegian Institute of Public Health, and the Norwegian 
Ministry of Health and Social Affairs (24). The study design, data collection, analyses, and 
publication were independent of the funding sources (24).  
3.3.5 Procedures: Data Collection & Examination 
There were two stages for data collection: baseline interview and health check (24). 
Baseline interviews were conducted at home to obtain information on socio-demographic 
characteristics and cardiovascular risk factors, and health check at a primary care clinic 
(polyclinic) examined the cardiovascular system including providing blood samples (24). 
Baseline Interviews: 
A trained interviewer filled out the questionnaire with the computer-assisted personal 
interviewing device on a tablet with an automatic time recording system for completing each 
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question (24). It took a median of 36 minutes to complete the questionnaire with a series of 
questions with detailed questions on alcohol use (24). Some of the sections related to the 
purpose of this thesis include socio-demographic factors, physical activity, smoking status, 
disease history, and CAGE score for detection of problem drinking. For CAGE questions, time 
reference used in KYH was “past 12 months” rather than “ever”, which was used in the original 
questionnaires as well as Ark.2000 (24). 
Health Check Examination: 
Health check included both a questionnaire and a physical examination (24). The 
questionnaire regarded past medical history, and it was administered by either a nurse or a 
cardiologist. It took three hours for the whole health check, and all the aspects followed the 
standard operating procedures. The use of medication was also measured by asking questions 
covering up to seven medications, and participants were asked to bring all medications to the 
health check. Assessment of hazardous alcohol use was made by AUDIT score, and questions 
on smoking from baseline interview were repeated. Some of the physical examination 
measurement related for the purpose of this thesis were: BPs, heart rates, anthropometry (BMI), 
lipids (total, HDL- and LDL-cholesterol), GGT and AUDIT. Due to the length of the health 
check, participants were asked to fast for 4 hours before the health check. Times of the last 
meal, drinks, and alcohol consumption within 24 hours were recorded at the arrival.   
Anthropometry: 
Weight was measured by TANITA BC418 body composition analyzer (TANITA 
Europe GmbH), and 98.1% of the participants for the health check completed with body 
composition data (24). Height was measured twice using Seca® 217 portable stadiometer (Seca 
Limited), and the completion rate was 99.9% (24).   
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Blood Pressure & Heart Rate: 
BP and pulse measurements were taken three times in a sitting position with an interval 
of two minutes using OMRON 705 IT automatic BP monitors (OMRON Healthcare) (24). 
98.9% of the participants for the health check completed the measurements (24).  
Blood Samples: 
Blood samples were collected and centrifuged at 4℃ for 15 minutes (24). Serum was 
transferred to barcoded 1.8 ml cryovials and frozen at -80℃ within two hours after 
venipuncture (24). This was confirmed for 100% of the samples in Arkhangelsk by time stamps 
and uniquely identified bar-code labels (24). The analyses of the samples were performed at 
the end of the study (24).  
Laboratory Analyses: 
All the samples were analyzed in Moscow. Total and HDL-cholesterol from serum were 
analyzed by the enzymatic color test using AU 680 Chemistry System Beckman Coulter, and 
LDL-cholesterol from serum was analyzed by the immuno-inhibition enzymatic color test with 
AU 680 Chemistry System Beckman Coulter (24). GGT from serum was analyzed by kinetic 
color test (IFCC) with AU 680 Chemistry System Beckman Coulter (24). 
3.4 Comparison of the Studies 
Table 6 shows the comparisons of the two studies based on recruitment, participants, 
period, diagnostic criteria, measurement of each variable. The number of participants listed was 
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Table 6: Comparison of study designs of Ark.2000 and KYH     Source: (24,48,50) 
 Ark.2000 KYH 
Recruitment Population attending annual medical 
exam at Semashko polyclinic 
Some workplaces and educational 
institutions 
General population (four 




 2132 participants (1087 males and 
1045 females) 
2222 participants (930 males and 
1292 females) 
Period May 15, 2000 – Nov. 17, 2001 Nov. 2, 2015 – Oct. 30, 2017 
Measurement: Devices Used 
Cholesterols Total & HDL: enzymatic color test by 
Hitachi 917  
LDL: for low triglycerides (<4 
mmol/l), the Friedwald’s formula was 
used for calculation. For >4 mmol/l, 
enzymatic colorimetric test by Hitachi 
737 
Total & HDL: enzymatic color 
test  
LDL: immune-inhibition 
enzymatic color test  
AU 680 Chemistry System 
Beckman Coulter for all tests 
BPs & RHR DINAMAP-R OMRON705 IT automatic BP 
monitors  
BMI - Height: Seca 217 portable 
stadiometer 
Weight: TANITA BC 418 body 
composition analyzer 
GGT Enzymatic colorimetric assay by 
Hitachi 917  
Kinetic color test by AU 680 
Chemistry System Beckman 
Coulter 
3.5 Statistical Analyses 
For analyses, participants above the age of 40 in Arkhangelsk were included from 
ARK.2000 (2132 total) and KYH (2222 total). For Ark.2000, descriptive statistics data were 
published and available although raw data were not available (48,50). For classical risk factors 
which were comparable between the studies, descriptive statistics including means, standard 
deviations, medians for GGT were performed using data published from Ark.2000 (48,50) and 
SPSS Statistics 25 for KYH. Those risk factors include total-, HDL-, and LDL-cholesterol, 
systolic and diastolic BP, RHR, BMI, GGT, AUDIT and CAGE scores, education, physical 
activity at work, and smoking. To account for confounders, each risk factor was stratified by 
age and sex. Participants were classified into groups with 10-year age using the nearest lower 
whole number.   
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For statistical significance, two-sample t-tests were performed using an online calculator 
(51) on the differences between the studies of continuous variables using means, standard 
deviations, and sample sizes. Cholesterols, BPs, RHR, BMI, GGT, and AUDIT were treated as 
continuous variables as they were reported as continuous variables in Ark.2000 (50). For 
categorical variables such as education, physical activity at work, and smoking, the proportion 
of participants for each category was reported. Using those proportions and sample sizes, chi-
square tests were performed with an online calculator (52) to see the significance in differences 
between the studies. For CAGE, means and standard deviations were not available for each age 
group from Ark.2000 as the proportion of participants in each CAGE score was reported. 
Categories from each categorical variable were different between the studies; hence, they 
were recategorized to make them comparable. Recategorizations of categorical variables are 
listed in table 7.  
The ten-year risk scores for CHD development calculated using the Framingham risk score 
were available from Ark.2000. Therefore, those scores from KYH were calculated using Excel 
and SPSS Statistics 25. Variables used to calculate Framingham scores include age, total- and 
HDL-cholesterol, systolic BP, and smoking status. The points for each variable were assigned 
using the tables provided in the Framingham Heart Study website (53).  For cholesterols, the 
unit was given in mg/dL in the Framingham risk score tables; however, the unit was given in 
mmol/L in KYH data.  Therefore, cholesterol values from KYH were multiplied by 38.67 to 
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Table 7: Recategorization of categorical variables of Ark.2000 and KYH    Source:(24,50) 
This thesis Arkhangelsk 2000 KYH 
Education 
Primary Primary school Incomplete secondary or lower  
 Professional school without secondary, PTU 
Secondary Secondary school Complete secondary 
Professional Secondary 
professional school  
 
Professional school with secondary  
 
 
Some college Specialized secondary 
 Incomplete higher 
Higher Graduated from 
college 
Higher 





(e.g. office work etc.) 
Sedentary occupation  
(most of your time sitting such as in an office) 
Standing 
occupation 
Work that requires a 
lot of walking  
(e.g. shop-assistant, 
waiter, etc.) 
Standing occupation  
(most of your time standing or walking. E.g. 
shop assistant, hairdresser, guard, etc.) 
Physical work 
 
Work that requires a 




Physical work  
(some physical effort including handling of 
heavy objects and use of tools. E.g. plumer, 
cleaner, nurse, sports instructor, electrician, 
carpenter, etc.) 
Heavy manual work  
(e.g. farmer, forestry, 
etc.) 
Heavy manual work  
(vigorous physical activity including handling of 
very heavy objects. E.g. docker, miner, 
bricklayer, construction worker, etc.) 
Smoking 
Never No, never smoked Never smoked 
Former Smoked previously No, ex-smoker 
Current Sometimes Yes, I smoke but less than 1 cigarette a day 
Yes, every day Yes, a regular smoker 
4 Results 
4.1 Study population 
The numbers of eligible participants from both studies as well as those for each age group 
are listed in table 8 below. The total of 2132 and 2222 participants from Ark.2000 and KYH, 
respectively, were included in the analyses.  
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Table 8: Study population – the number of participants included for analyses 
  Ark.2000 KYH 
Eligible 
- Above 40 
- Arkhangelsk  
Total 2132 2222 
Male 1087 930 
Female 1045 1292 
Age: 40-49 Male 447 280 
Female 420 411 
Age: 50-59 Male 308 324 
Female 305 422 
Age: 60+ Male 332 326 
Female 320 459 
4.2 Main findings 
4.2.1 Continuous Variables (Biomarkers, BPs, RHR, BMI) 
The following tables 9-10 show the means, the standard deviations, the number of valid 
entries, and the p-values for the differences between the studies for the continuous variables 
such as biomarkers (total and HDL-cholesterol), systolic and diastolic BPs, RHR, and BMI. 
For men, total cholesterol and systolic BP have slightly decreased while diastolic BP, 
RHR, and BMI have slightly increased for all the age groups. HDL-cholesterol improved for 
all groups. For age 40-49, significant differences were observed in diastolic BP, RHR, and BMI 
while total cholesterol, HDL-cholesterol, diastolic BP, and RHR were significant for age 50-
59. For those above 60 years of age, the increase in HDL-cholesterol, diastolic BPs, and BMI 
and the decrease in systolic BP were significant. Standard deviations for both cholesterols were 
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Table 9: Comparison of continuous variables and their means, standard deviations, valid 
numbers, differences of means (p-values) for men age 40-49, 50-59, and 60+                    
Men  Age 40-49 Age 50-59 Age 60+ 
 Ark. 2000 KYH Ark. 2000 KYH Ark. 2000 KYH 
Total 
cholesterol 


















 p=0.185 p=0.046 p=0.171 
HDL-
cholesterol 


















 p=0.714 p<0.001 p<0.001 


















 p=0.498 p=0.311 p=0.003 





































 p=0.019 p<0.001 p=0.344 


















 p<0.001 p=0.085 p<0.001 
For women, total cholesterol has slightly and systolic BP has greatly decreased while 
diastolic BP and RHR have increased. An improvement in HDL-cholesterol was seen, but BMI 
remained similar between the studies. For age 40-49 and 50-59, HDL-cholesterol, systolic and 
diastolic BPs, and RHR were significant while the significant differences were seen in total- 
and HDL-cholesterol, systolic BP, and BMI for ages above 60. Standard deviations for both 
cholesterols in both studies were narrow, implying there is small variation within individuals 
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Table 10: Comparison of continuous variables and their means, standard deviations, valid 
numbers, differences of means (p-values) for women age 40-49, 50-59, and 60+                
Women  Age 40-49 Age 50-59 Age 60+ 
 Ark. 2000 KYH Ark. 2000 KYH Ark. 2000 KYH 
Total 
cholesterol 


















 p=0.494 p=0.153 p=0.004 
HDL-
cholesterol 


















 P<0.001 p<0.001 p<0.001 


















 p<0.001 p<0.001 p<0.001 


















 p<0.001 p<0.001 p=0.915 
RHR 70.2   
(9.1) 
N=420 
73.5   
(9.9) 
N=388 












 p<0.001 p=0.035 p=0.072 


















 p=0.181 p=0.853 p<0.001 
Source: (50) 
4.2.2 Categorical Variables 
The following tables 11-12 show the proportion (%) of each category for other 
characteristics such as education, physical activity, and smoking for men and women. For men, 
both educational attainment and smoking improved for all age groups.  However, the proportion 
of physical work has declined for ages 40-49 and 50-59 while it has increased for ages above 
60. 
For women, educational attainment increased as well as the proportion of physical work, 
especially for higher ages. However, the proportion of never smoker decreased while former 
and current smokers increased for all age groups. 
 
Page 28 of 59 
Table 11: Risk factors with categorical variables (education, physical activity at work, 
and smoking) for men                                                                                               Source:(50) 
Men  Age 40-49 Age 50-59 Age 60+ 
 Ark. 2000 KYH Ark. 2000 KYH Ark. 2000 KYH 
Education (%) 
Valid number N=447 N=280 N=308 N=324 N=332 N=326 
Primary 4.7 7.9 6.2 5.6 19.0 14.7 
Secondary 22.8 8.6 15.3 10.2 18.7 12.3 
Professional 51.2 47.1 53.0 54.6 43.1 40.8 
Higher 21.3 36.4 25.6 29.6 19.3 32.2 
Difference p<0.001 p=0.231 p<0.001 
Physical Activity at Work (%) 
Valid number N=447 N=249 N=308 N=240 N=332 N=120 
Sedentary occupation 22.6 46.2 30.2 48.3 50.3 41.7 
Standing occupation 23.3 17.7 27.6 17.9 33.7 22.5 
Physical Work 54.1 36.1 42.2 33.8 15.9 35.8 
Difference p<0.001 p<0.001 p<0.001 
Smoking (%) 
Valid number N=447 N=267 N=308 N=312 N=332 N=311 
Never 28.2 28.1 17.9 24.0 25.3 25.7 
Former 17.7 35.6 22.4 37.8 34.9 44.4 
Current 54.1 36.3 59.8 38.1 39.7 29.9 
Difference p<0.001 p<0.001 p=0.018 
Table 12: Risk factors with categorical variables (education, physical activity at work, 
and smoking) for women                                                                                         Source:(50) 
Women  Age 40-49 Age 50-59 Age 60+ 
 Ark. 2000 KYH Ark. 2000 KYH Ark. 2000 KYH 
Education (%) 
Valid number N=420 N=411 N=305 N=422 N=320 N=459 
Primary 2.9 3.9 4.9 4.8 32.5 10.7 
Secondary 13.8 3.4 16.1 6.2 23.8 10.0 
Professional 51.6 44.0 46.2 55.4 28.1 54.7 
Higher 31.7 48.7 32.8 33.6 15.6 24.6 
Difference p<0.001 p<0.001 p<0.001 
Physical Activity at Work (%) 
Valid number N=420 N=365 N=305 N=297 N=320 N=134 
Sedentary occupation 53.1 53.7 52.5 56.2 65.6 47.0 
Standing occupation 35.7 29.0 35.4 22.2 29.1 26.9 
Physical Work 11.2 17.3 12.1 21.6 5.3 26.1 
Difference p=0.020 p<0.001 p<0.001 
Smoking (%) 
Valid number N=420 N=391 N=305 N=403 N=330 N=446 
Never 69.0 57.0 86.6 65.0 96.6 83.9 
Former 6.9 23.3 4.6 15.9 2.2 9.6 
Current 24.0 19.7 8.8 19.1 1.2 6.5 
Difference p<0.001 p<0.001 p<0.001 
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4.2.3 Alcohol-Related Values 
The following tables 13-14 show factors related to alcohol. Those include GGT, total 
AUDIT scores, proportions of AUDIT scores of above eight, proportions of each CAGE score, 
and the number of alcohol units consumed per capita. Values for GGT, total AUDIT scores, 
and alcohol units consumed include means, standard deviations, valid numbers, medians, and 
p-values for differences between the studies. The information on the frequency of alcohol 
drinking was not available for Ark.2000 due to how it was reported in the publications. Also, 
the amount of alcohol consumed in alcohol units was per week for Ark.2000 and per day for 
KYH. Due to the differences in the period, p-values were not reported for the amount of alcohol 
consumed. 
Table 13: Alcohol-related variables (GGT, AUDIT, CAGE, and consumption) for men 


























Median 34.0 32.1 38.0 33.4 30.0 28.7 
Difference Mean p=0.757 p=0.203 p=0.647 


















Difference p=0.031 p<0.001 p<0.001 
AUDIT≥8 (%) 45.0 38.0 49.5 32.2 29.4 17.7 
AUDIT≥13(%) 14.8 11.7 14.7 9.3 9.2 3.9 
CAGE score (%) 
Valid number N=400 N=280 N=279 N=324 N=238 N=326 
CAGE 0 55.8 50.4 49.1 63.3 63.0 68.1 
CAGE 1 23.5 19.6 24.4 12.0 22.3 12.0 
CAGE 2 11.0 16.1 14.7 11.7 9.2 10.1 
CAGE 3 7.8 9.3 8.6 9.0 4.6 7.7 
CAGE 4 2.0 4.6 3.2 4.0 0.8 2.1 
Difference p=0.051 p<0.001 p=0.011 
Amount consumed 
(alcohol units)* 


















*Ark. 2000 per week, KYH per day              Source: (48,50) 
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For men, GGT has slightly decreased, but the values are still high for all the groups. The 
standard deviation for each age group was large, suggesting large individual differences in 
alcohol consumption. The mean total AUDIT score and the proportion of participants with the 
total AUDIT score of eight or higher also decreased. The proportion of those with a CAGE 
score of two or higher has decreased only in the age 50-59. For those above the score of three 
increased for all the age groups. These differences in CAGE scores suggest there might have 
been underreporting of alcohol drinking in Ark.2000 as well as KYH. Although alcohol 
consumption in Arkhangelsk seems declined over the years, it still remains high.  
Table 14: Alcohol-related variables (GGT, AUDIT, CAGE, & consumption) for women 


























Median 20.0 17.8 23.0 21.8 24.0 22.4 
Difference Mean p=0.019 p=0.148 p=0.297 
Total AUDIT 
score 


















Difference p<0.001 p<0.001 p<0.001 
AUDIT≥8 (%) 9.0 4.1 5.9 2.5 2.0 0.2 
AUDIT≥13(%) 2.3 0.7 0.0 0.5 0.0 0.0 
CAGE score (%) 
Valid number N=345 N=411 N=219 N=422 N=99 N=459 
CAGE 0 70.1 83.9 77.6 88.6 91.9 93.0 
CAGE 1 18.8 8.8 17.8 5.5 7.1 4.4 
CAGE 2 9.0 5.4 3.2 3.6 1.0 2.6 
CAGE 3 1.7 1.5 1.4 1.9 0.0 0.0 
CAGE 4 0.3 0.5 0.0 0.5 0.0 0.0 
Difference p<0.001 p<0.001 p=0.341 
Amount consumed 
(alcohol units)* 


















*Ark. 2000 per week, KYH per day              Source: (48,50) 
For women, the mean GGT slightly decreased except for age 50-59 while the median 
decreased for all the groups, suggesting a decline in alcohol consumption although the 
individual difference seems to be large. The decline in the mean total AUDIT score was 
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significant for all the age groups, and the proportion of participants with an AUDIT score of 
eight or higher decreased at all the groups whereas the proportion of those above 13 increased 
for age 50-59. The proportions of participants with lower CAGE score (below one) increased 
for all age groups except age 40-49 while those of higher CAGE score (two to four) decreased 
except for ages above 60. 
4.2.4 Ten-Year Risk Scores for CHD Development 
The following table 15 shows ten-year risk scores of developing CHD for men and 
women for groups of five-year age range above 40 with means, standard deviations, and valid 
numbers. For Ark.2000, valid numbers were available only for the ten-year age range.  For 
men, each age group below 60 had an increased score while that of above 60 had a decreased 
score. As the age group goes higher, the larger the decrease of the scores between the studies 
was (7.6 lower for age 70-74). For women, the risk scores decreased drastically over the years 
with the highest decrease of 8.74 for the age 60-64.    
Table 15: Ten-year risk scores of developing CHD for men and women (means, standard 
deviations, and valid numbers)                                                                              Source (46,50) 
Age Men  Women 
 Ark.2000 KYH Ark.2000 KYH 
  Valid  Valid  Valid  Valid 
40-44 5 
447 

























65-69 25 18.72 (5.59) 93 13 6.87 
(4.54) 
167 
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5 Discussion 
5.1 Main findings 
For men, total- and HDL-cholesterol, systolic BP, GGT, total AUDIT, and smoking have 
improved over the years while diastolic BP, RHR, BMI, physical activity at work, and CAGE 
have increased. Although most of the variables related to alcohol decreased and suggest a 
reduction in alcohol consumption, GGT remains high for all the age groups. Reduction in some 
of the risk factors has improved the risk scores for developing CHD. However, a further 
decrease in risk factors would be necessary for a reduction in CVD prevalence. For women, 
total and HDL-cholesterol, systolic BP, GGT, total AUDIT, CAGE, education, physical activity 
at work improved while diastolic BP, RHR, and smoking increased. BMI remained similar 
between the studies. There were larger declines in ten-year risk scores for CHD development 
for women compared to men. For further reduction in risk factors, control of BMI and 
prevention of increasing smoking prevalence would be necessary. 
5.1.1 Total cholesterol & HDL-cholesterol 
For men, changes in the mean total cholesterol were not significant except for age 50-
59. Changes in the mean HDL-cholesterol were significant for above 50 years old. For women, 
the mean total cholesterol values were similar for age 40-49 and 50-59, but the differences were 
larger and significant for above 60 years old. Differences in the mean HDL-cholesterols were 
significant at all age groups.  
Cholesterol is a lipid found in blood, and it can be deposited, creating plaque when in 
high abundance. Sudden breakage of those clots can cause a heart attack or stroke (55). HDL-
cholesterol is considered to be the good cholesterol as it transports excess cholesterol back to 
the liver (55). Genetics and age play roles in high cholesterol; however, unhealthy lifestyle 
choices such as unhealthy diet, smoking as well as sedentary lifestyle affect cholesterol as well 
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(55). Reduction in total cholesterol in men aged 50-59 and women above 50 years old and 
increase in HDL-cholesterol in men above 50 and women of all age groups could suggest 
improvements in these modifiable risk factors for cholesterol in all age groups in both genders. 
However, it is likely that there are differences in improvements among different age groups and 
between genders, suggesting older age groups and women were more health-conscious.    
5.1.2 Systolic & Diastolic Blood Pressures and Pulse Pressure 
For men, the decreases in the systolic BP were significant only for participants above 
60 years of age. However, the increases in the diastolic BP were significant for all age groups. 
For women, the decreases in the systolic BPs were significant for all ages. The increases of 
diastolic BPs were significant for age 40-49 and 50-59.  
BPs are determined by the amount of blood pumped by the heart and the arterial 
resistance (56). Systolic BP is the arterial pressure from ventricular contraction pushing blood 
from the heart, typically around 120 mmHg while diastolic BP is from ventricular relaxation, 
typically around 80 mmHg (57). The risk factors of high BP include age, race, family history, 
chronic conditions, obesity, physical inactivity, smoking, high sodium and low potassium in 
diet, alcohol, and stress (56). BPs can also be modified by medications. Decreases in systolic 
BPs in both genders could suggest improvements in the modifiable risk factors of hypertension 
or high BP as well as medication use. There was also a gender difference in improvement in 
systolic BP. The decrease in systolic BP was larger in women compared to men. The largest 
reduction was observed in women over 60 years of age with 13.2 mmHg, 8.8% reduction. This 
could be due to the higher tendency of women seeking healthcare compared to men; thus higher 
number of women using medication to control BPs (10).   
Although systolic BPs in both genders improved, diastolic BP has increased in both 
genders. This could be due to the differences in the devices used for measurements in the 
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studies. There were several validation studies for both DINAMAP and OMRON705 IT. 
OMRON705 IT was tested on participants with different BP groups including children and 
adolescents and satisfied both the British Hypertension Society criteria (A-very good) and the 
Association for the Advancement of Medical Instrumentation SP10 Standard less than ±5 (with 
a standard deviation of 8) mmHg (58,59).  
However, there were contradicting results for DINAMAP. One study measured ankle 
systolic BP on adults using DINAMAP1846 SX and Doppler and concluded DINAMAP as a 
more precise and useful tool for epidemiological studies (60). Another study compared 
DINAMAP and the conventional auscultatory method to measure BP in infants and children 
and concluded DINAMAP as more preferred method compared to the conventional 
auscultatory method as the mean error was smaller and reflected the direct radial artery pressure 
well (61).  
Yet another study recognized DINAMAP disregarding certain systolic BP values in 
three epidemiological studies due to the algorithm used to improve the precision of the device 
(62). There were also other articles that question the accuracy of the DINAMAP model 8100 
for measuring diastolic BP. It was found that the device achieved a grade B for systolic BP 
measurements and a D (poor) for diastolic BP based on the British Hypertension Society criteria 
(63,64). Both the accuracy and inaccuracy of DINAMAP devices were reported on different 
devices from the ones that were used in Ark.2000 study. The company that produced 
DINAMAP-R was acquired by another healthcare company in 2000 (65). The validation of 
DINAMAP-R could not be found since the DINAMAP website no longer exists. 
Another possible explanation for systolic and diastolic BPs moving to different 
directions might be due to pulse pressure change between Ark.2000 and KYH. Pulse pressure 
is the differences between systolic and diastolic BPs (66). For those above 60 years of age, a 
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pulse pressure of above 60 is an indicator of CVDs and suggests losses in elasticity in aorta 
leading to leaky heart valves (valve regurgitation) (66). Pulse pressure of lower than 40 also 
indicates poor cardiovascular function (66). Elevated pulse pressure indicates aortic stiffness 
from high BP, damages of arterial walls from plaque, and lack of elasticity in blood vessels 
(atherosclerosis) (66). Pulse pressure was lower in KYH than Ark.2000 at all age groups for 
both genders. This suggests an improvement in cardiovascular functions. Although diastolic 
BP increased over the years, the improvement seen in both systolic BP and pulse pressure 
suggests recent positive trends in improvement of CVD risk factors as well as CVD mortality. 
5.1.3 Resting heart rate 
RHRs for both men and women increased in all age groups with a significance for those 
aged 40-49 and 50-59 for men and women. Normal heart rates range between 60 and 100 beats 
per minute with lower RHRs indicating efficient cardiovascular functions (67). Factors for an 
increase in heart rate include age, physical inactivity, smoking, disease history (having CVDs, 
high cholesterol, or diabetes), air temperature, emotions, body size, and use of medications (67). 
Although there was a decrease in smoking prevalence in men, a decrease in physical activity at 
work might have increased resting heart rate as it is another risk factor. An increase in RHR in 
women might have been affected by the increase in the prevalence of smoking in women. 
5.1.4 Body Mass Index, Physical Activity at Work, and Education 
For men, BMI has increased between 2000 and 2017. The differences in BMI were 
significant for age 40-49 and above 60. This might be due to different sample populations with 
different proportion of physical work occupations as BMI is a measure of obesity and physical 
inactivity. For the age groups 40-49 and 50-59, sedentary occupation increased whereas 
physical work including heavy manual work decreased. For those above 60 years of age, 
sedentary and standing occupation decreased while physical and heavy manual work increased. 
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In fact, the proportion of sailors in Ark.2000 was higher compared to that of KYH (50). Sample 
population representing the general population in KYH might have given the impression of a 
decrease in the proportion of participants with physical work for younger age groups.  
These changes in the proportion of different occupations could also be related to 
educational attainment. The proportion of higher education increased for all age groups in 
KYH. However, this could also be thought of the sample population in KYH representing the 
general population well as sailors do not require to have higher education. Thus, those with 
higher education were underrepresented in Ark.2000. In addition, misclassification of 
education groups might have occurred as the questions on educational attainment were 
formulated differently between the studies. Nevertheless, it is also possible that the educational 
attainment has increased over the years as the youngest age group (40-49) has the highest higher 
education attainment.  
The information on physical activity at leisure time was not available; however, these 
age groups are working-age groups and spend a great amount of time at work. Therefore, 
physical activity at work is an important factor to control BMI. One study looked at BMI and 
workplace characteristics such as decision making, job flexibility and workplace harassment 
(68). They found out that greater decision making and job flexibility increased physical activity 
(68). Therefore, increasing physical activity at work is possible even with sedentary 
occupations. In fact, there are multiple studies and policy guidelines recommending to increase 
workplace physical activity as workplace physical activity can lead to higher productivity, 
lesser sick leaves, and lower healthcare costs (69,70).   
For women, BMI was similar in both studies for ages 40-49 and 50-59. For those above 
60, BMI has increased with significance. With social changes in female occupations, sedentary 
and standing occupation decreased while physical and heavy manual work increased at all age 
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groups. However, misclassification could also be a possible explanation for the increase in 
physical work as the occupation questions were formulated differently between the studies. 
Despite the increase in physical work at all age groups, BMI increased in the age group above 
60. This might have been related to the educational attainment. Even though higher educational 
attainment was achieved at all age groups, the proportion of the participants with higher 
education was lowest for the group above 60. The association of higher educational levels and 
lower BMI was found in several studies (71,72). Those participants with higher educational 
attainment might have cared about their health by increasing physical activity and had access 
to healthier food due to the tendency to have higher income with higher educational attainment.     
5.1.5 Smoking & Education 
For men, never and former smokers increased while current smokers decreased for all 
age groups. This reduction in current smokers might be influenced by educational attainment. 
A study of Australian twins found nine months of reduction in smoking duration as the 
educational attainment increases by one year (73).  
For women, the comparison of Ark.2000 and KYH showed the opposite trend. The 
proportion of never smoker decreased while former and current smoker increased except for 
current smokers of age 40-49. Although the proportion of women with higher education 
increased, there was also an increase in the number of current smokers. This might be due to 
the thought of losing weight from smoking. In fact, this idea has started around the 1930s from 
an advertisement to recommend women smoking: “reach for a cigarette instead of a sweet”(74). 
Some smokers think weight gain as a drawback of smoking cessation (74).   
The research which looked at consequences of smoking on body weight concluded that 
smoking can reduce appetite and body weight by nicotine increasing expenditure of energy in 
the short term (75). However, those who smoke do not seem to know about the long-term effect 
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of smoking on body weight. The addictive effect of nicotine is well known (76,77). Heavy 
smoking is associated with weight gain compared to light smoking and non-smoking as it is 
related to other risk factors such as physical inactivity and poor diet (75). The authors also 
concluded that smoking increases the risk of metabolic syndrome, diabetes, and CVDs (75). 
Therefore, increasing awareness of the negative effect of smoking on body weight and offering 
support for smoking cessation will be important for CVD prevention. This is especially 
essential for women to stop the current trend of an increase in smoking.   
5.1.6 GGT, CAGE, AUDIT & Alcohol Consumption 
For men, both the mean and the median of GGT decreased over the years for all the age 
groups although they were not statistically significant. For women, both the mean and the 
median of GGT decreased for all the age groups except for the mean GGT for age 50-59. The 
reduction in GGT was significant for age 40-49.  
GGT is an enzyme primarily found in kidney, liver, and pancreas to transport peptides 
and amino acids to cells (78,79). An elevated level of GGT suggests alcohol abuse and is 
associated with CVDs due to its involvement in atherosclerosis (78,80). The reference levels of 
GGT for adult men and women are 8-61 and 5-36 U/L but vary between studies (79). One study 
categorized GGT for men and women as normal low (<14 and <9U/L), normal high (14-27 and 
9-17 U/L), moderately elevated (28-41 and 18-26 U/L), increased (42-55 and 27-35 U/L), and 
highly elevated (≥56 and ≥36 U/L, respectively) (80). With this categorization, the current GGT 
levels for all the age groups in men are at an increased level while those are moderately elevated, 
highly elevated, and increased for women aged 40-49, 50-59, and above 60. These GGT levels 
indicate high alcohol consumption in Arkhangelsk population. Even though the levels have 
been decreasing, there is a concern that GGT has a large number of false negatives (78). Hence, 
the use of AUDIT and CAGE would be beneficial in addition to GGT.  
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Even though both AUDIT and CAGE are self-reporting questionnaires, both have been 
validated for its sensitivity and specificity (28,81–83). Some researchers found AUDIT more 
reliable than CAGE as CAGE has only four questions; however, adjusting the number of item 
criteria to two or three instead of four (88, 83, 81, 94% for sensitivity and specificity of two and 
three positive response, respectively), CAGE was considered to satisfy the validity (81,82).  
From Ark.2000 to KYH, the mean of the total AUDIT scores have been significantly 
decreased for all the age groups in both genders. The proportion of AUDIT scores of equal or 
above eight, indicating hazardous drinking, also decreased for both gender and all age groups.    
On the other hand, the CAGE score indicated the opposite results for men and women. 
For men, the proportion of men having a CAGE score of 0 and 1 decreased except for CAGE 
score 0 for age 50-59. Higher CAGE scores increased for all the age groups. For women, CAGE 
scores were similar between the studies for all the age groups except age 40-49. For this group, 
the positive trend of having lower scores was seen. Reduction of CAGE scores in women but 
not men suggests underreporting in Ark.2000. Underreporting of alcohol consumption is also 
possible in KYH as well.  
Nevertheless, the decline in GGT levels and AUDIT scores for both genders and CAGE 
score for women could suggest a positive trend of reduction in alcohol consumption in 
Arkhangelsk. The following table 17 shows the consumption of total alcohol and different types 
of alcohol consumed in dL in Arkhangelsk (Arkhangelsk oblast – Nenets autonomous okrug) 
between 2010 and 2017 as 2000 data was only available for the whole Arkhangelsk region (84).    
The total consumption of alcohol in dL decreased by 436,500dL between 2010 and 2017 
(84). Not only the consumption of alcohol but also the types of alcohol consumed have changed 
over the years. The consumption of vodka and cognac decreased while beer consumption 
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increased (84). As vodka and cognac have higher alcohol content than beer, it might have had 
an effect to lower GGT and lead to the reduction of total AUDIT scores. 
Table 16: Yearly alcohol consumption in dL in Arkhangelsk                            Source: (84) 
Year Vodka & Liquor Cognac Wine Sparkling wines Beer Total 
2010 1,902,000 143,300 1,431,200 219,600 4,815,800 8,511,900 
2016 1,376,300 105,600 940,900 205,000 5,808,900 8,436,700 
2017 1,235,300 103,900 1,006,900 169,800 5,559,500 8,075,400 
5.1.7 Ten-year risk of developing CHD 
Although the ten-year risk of developing CHD has increased for ages between 40 and 
59 in men, it has decreased significantly in women of all age groups. The largest reduction was 
found in women aged 60-64. However, the sample sizes were smaller in KYH compared to 
Ark.2000, which might have affected the result. In addition, some of the risk factors such as 
GGT, AUDIT, CAGE, education, physical activity at work were not included in the calculation 
of ten-year risk of developing CHD. Since the reduction in alcohol consumption in men was 
not included in the calculation, it might have led to the large gender difference in the ten-year 
risk of developing CHD. 
Nevertheless, these factors that were not included in the calculation might have affected 
other risk factors that were in the calculation as these factors were interconnected. The 
improvements in CVD risk factors such as reductions in total cholesterol, systolic BP, pulse 
pressure, smoking, GGT, and AUDIT as well as increases in HDL-cholesterol and educational 
attainment suggest the reduction in ten-year risk of CHD development for ages above 60 in 
men. For ages below 60, slight increases in BMI and RHR and still high consumption of alcohol 
seen from GGT, AUDIT, and CAGE might have hindered the benefits of improvements in other 
risk factors. For women, a slight reduction in total cholesterol, systolic BP, GGT, and AUDIT, 
as well as increases in HDL-cholesterol, physical activity at work, and educational attainment 
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seemed to favor a reduction in the ten-year risk of CHD development especially in ages above 
the age of 60.  
5.2 Limitations & Strength 
5.2.1 Study population 
The total number of participants included for the analyses were similar in both Ark.2000 
and KYH. However, the ways participants were recruited differed in the two studies. For Ark. 
2000, although some workplaces and educational institutions were invited, most of the 
participants were recruited at a polyclinic while attending annual medical examinations. Since 
it was a mandatory annual health check for sailors, the proportion of sailors were 
overrepresented in Ark.2000. However, participants were recruited from the general population 
for KYH by randomly selecting individual addresses. Since those two study populations were 
recruited differently, it is important to consider selection bias in each study. According to 
Henderson, “Selection bias in epidemiological studies occurs when there is a systematic 
difference between the characteristics of those selected for the study and those who are not” 
(85).   
For Ark.2000, participants attended annual medical examinations through workplaces 
and educational institutions, which means they were healthy enough to work or study. This 
indicates healthy worker effect, which is defined by Last as “a phenomenon initially observed 
in studies of occupational diseases: Workers usually exhibit lower overall death rates than the 
general population because the severely ill and chronically disabled are ordinarily excluded 
from employment” (86). In fact, the proportions of sailors and fishermen in men who are 40-
59 in the study population were large compared to other occupations due to the polyclinic used 
to serve mainly sailors, fishermen, and their families (50). Participants with manual labor jobs 
including fishery would have to be healthier to perform manual labor jobs. Therefore, there 
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might have been an underestimation of CVDs due to participants being healthy. In addition, the 
proportion of the male unemployed population was underrepresented in the study as most 
people go to annual medical examinations through workplaces (46,48).  
Moreover, the study population was more educated than the general Arkhangelsk region 
population. Manual labor jobs, which include sailors and fishermen, are unlikely to require 
higher education. Therefore, even with the higher proportion of younger males being sailors 
and fishermen, the sample population of Ark.2000 represented somewhat general population in 
terms of educational attainment. However, the higher educational attainment of the sample 
population is likely to be due to urban-rural differences that there are more educated people 
working in an urban setting (48). In fact, the Programme for International Student Assessment 
(PISA) scores for secondary students in Russia were higher in urban areas compared to rural 
areas between 2000 and 2009 (87). This was explained by the socioeconomic differences of 
students, urban schools having a significantly higher proportion of students whose parents have 
higher education (87). Even though the male unemployed population was underrepresented, 
age distributions of the study sample and the general Arkhangelsk population were relatively 
similar (48).  
Furthermore, non-response bias arising from having a large number of non-responders 
can be disregarded for this study as they have recruited participants who were already at the 
polyclinic. Hence, the response rate for the study was 98% (40 non-participants and 43 without 
questionnaires out of 4129 recruited for the study), which was a strength of Ark.2000 (50).   
For KYH, random addresses from four districts with different socio-demographic 
characteristics were selected to represent the general Arkhangelsk population; therefore, it is 
likely that the study population represented the general population. However, there could be 
non-response bias as the response rates calculated based on the addresses matching expected 
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and observed age and sex of occupants were lower for the younger male and higher for the 
older female with an overall response rate of 68.2% in Arkhangelsk (24). There were general 
tendencies of non-responders being younger male with lower educational level without regular 
paid employment and responders with a history of CVDs with a high attendance of medical 
examination except for those with previous stroke (24). In addition, participants living far from 
the clinic were also less likely to complete the medical examinations (24). However, the 
proportion of baseline questionnaire responders who attended medical examinations for all ages 
were 96% in Arkhangelsk (24).  
In order to rule out selection bias due to non-response, Cook et al compared the 
educational attainment of the sample population and the general Arkhangelsk population from 
the Russian census 2010 (24). Although higher education attainment was higher for younger 
age and lower for older age in the sample population compared to the general Arkhangelsk 
population, the overall ratios of observed to expected for those completed baseline survey and 
health check were 0.98 and 0.99, showing the sample population representing the general 
Arkhangelsk population (24).  
Even though the study populations were collected differently, both studies are likely to 
be comparable. The representation of the general Arkhangelsk population was seen in KYH. 
Although there seems to be an overrepresentation of sailors and fishermen for younger male 
age groups inArk.2000, the sample population seems to be representing the general population 
in terms of educational attainment and age distribution. 
5.2.2 Data collection & Analyses 
There are also possibilities of information biases, specifically misclassification bias, 
recall bias, self-reporting bias and social desirability bias and measurement error bias. 
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Kesmodel describes information bias as inaccurate measurement and or recording of any 
information used in a study (88).  
A possible source of misclassification would be altering categories of variables. For the 
purpose of the comparison between the two studies in this thesis, some of the categories were 
reclassified. However, these changes were carefully made by comparing the description of each 
category from both studies, and some comparisons were dropped when questions were 
formulated differently to avoid further misclassification.  
Recall bias occurs due to participants who have experienced CVDs previously might 
recall exposure to risk factors better than those who have not experienced CVDs. This would 
lead to over-reporting of exposures in those who have experienced CVDs but underreporting in 
those who have not experienced CVDs. Underreporting reduces the effect of a dose-response 
relationship (88).   
Underreporting is closely related to self-reporting and social desirability bias. Social 
desirability bias occurs when private or sensitive information such as dietary intake and 
substance use are collected (89). For questionnaires and surveys, participants might choose 
categories that are preferred or approved by society since it is self-reported. This leads to 
underreporting of alcohol consumption and smoking. In order to reduce self-reporting and 
social desirability bias, validation of self-reporting questionnaires are important (89). In both 
Arkhangelsk 2000 and KYH, alcohol consumption was measured using validated questions 
such as AUDIT and CAGE. The use of the same tests in both studies enabled the direct 
comparison of alcohol consumption in this thesis, which is one of the strengths.  
Another bias that needs to be considered is measurement error bias. Measurement error 
bias occurs due to the inaccuracy of devices used to measure outcomes, conditions of 
laboratories, and self-reported measurements (89). In order to avoid observer bias caused by 
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differences in measurements among diverse observers, health examinations and baseline 
questionnaires were carried out by trained professionals in both studies (24,48). Questionnaires 
from both studies were also double translated (forward and backward between English and 
Russian) to avoid the bias (24,48). These attempts were strengths of the studies.  
Some of the variables in Ark.2000 and KYH such as biomarkers and anthropometry 
were measured differently using different devices, which might have affected the results. To 
avoid measurement error bias from devices, frequent calibration of devices, controlling 
environment, and validations of devices used in the studies are essential. In both studies, BP 
measurements were performed in a different room with only one participant at a time (24,48). 
Even though validation and frequent calibrations of devices were performed in each study, there 
was no validation or calibration between the studies. Therefore, it is possible that the results 
might be affected by measurement error. In addition, participants knowing that they are part of 
a study or being nervous at health checks could lead to a measurement error. For example, BPs 
could fluctuate by participants being at a polyclinic. For this reason, the means of second and 
third measurements of systolic and diastolic BPs from both studies were used for the analyses. 
Furthermore, confounding is another factor that needs to be considered when analyzing 
multiple variables. Aronson and Delgado-Rodriguez describe a confounder as a variable which 
is a risk factor for an effect and modifies the association between the exposure and the outcome 
(90,91). Since raw data was not available from Ark.2000, adjustment for age or other factors 
was not performed on KYH data. However, the descriptive statistics published from Ark.2000 
was stratified by age and sex, so KYH data were also stratified by age and sex to control for 
confounding. Nevertheless, there might be other confounders that were not adjusted due to the 
unavailability of raw data from Ark.2000.   
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5.2.3 Strengths 
Strengths of the studies were the locations of the polyclinics in both studies. Being in or 
close to the city center made it easier for participants to attend health checks (24,48). In 
addition, data collection in KYH was done electronically for both baseline questionnaires and 
health checks, which eliminated recording errors (24). Moreover, this thesis was the first to 
compare CVD risk factor changes in Arkhangelsk to the knowledge of the author. Sampled 
populations in both Ark.2000 and KYH relatively represented the general Arkhangelsk 
population. Since Russia is a larger country with a lot of diversity, it might be difficult to 
generalize the result of this thesis. However, the results would be beneficial to understand the 
recent downward in CVD deaths in similar population-sized cities in Russia.  
5.3 Further Research 
The accuracy of the comparisons provided in this thesis could be improved by conducting 
longitudinal studies on the same population. Cohort study and time trend analysis would be 
possible by conducting the same study again on the same individuals. The use of the same 
questionnaires, protocols, and measuring devices would reduce biases and would provide more 
reliable results. More accurate and reliable results would help to explain the recent decline in 
CVD mortality in Russia and be beneficial for future preventive strategies. Communicating the 
knowledge gained through these studies to the general public in Arkhangelsk would be 
beneficial for future preventive strategies. 
6 Conclusion 
Although some of the changes were small, total- and HDL-cholesterol, systolic BP, GGT, 
total AUDIT, and education improved for both genders between Ark.2000 and KYH. Smoking 
for men, CAGE and physical activity at work for women have also improved between the 
studies. The decline in the ten-year CHD risk scores was larger for women compared to men. 
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This might be due to the reduction in the important risk factor for Russian male, alcohol 
consumption, not included in the calculation. Nevertheless, the reduction in alcohol 
consumption could modify other risk factors that were included in the calculation and could 
contribute to CHD reduction. Controlling alcohol consumption in men and smoking and BMI 
in women would be beneficial for further reduction of CVD risk factors as well as its 
prevalence. Conducting longitudinal studies and communicating the results to the general 
public in Arkhangelsk would be necessary and beneficial for the prevention of CVDs and a 
further reduction in its mortality in Arkhangelsk as well as Russia.     
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8 Appendix 
Questionnaire Arkhangelsk 2000  
(only those questions included in the thesis are listed) 
 
1. Personal information  
1.1. SEX: male   female    
1.2. AGE:    years 
 
2. Occupational activity and 
social conditions  
2.1. EDUCATION:  
primary school       
secondary school       
secondary professional school   
some college        
graduated from college      
3. Heredity and disease history  
3.2. DO YOU NOW HAVE OR HAVE  
YOU EVER HAD: Yes No Don’t know  
myocardial infarction        
angina pectoris                  
cerebral stroke or brain  
haemorrhage (insult)        
sugar diabetes                    
high blood pressure  
(hypertensive disease)       
pancreatitis                        
hepatitis or cirrhosis of the liver      
nephritis            
stomach bleeding           
dyspepsia (digestive trouble)           
stomach or duodenal ulcer          
brain concussion           
trauma to the extremities or  
to the spine            
5. Physical activity  
5.2. PLEASE ESTIMATE YOUR LEVEL  
OF PHYSICAL ACTIVITY IN THE  
WORK PLACE:  
During the last year you have had:  
mostly sedentary work (e.g. office  
work, etc.)       
work that requires a lot of walking  
(e.g. shop-assistant, waiter, etc.)    
work that requires a lot of walking  
and lifting (e.g. postman,  
construction, etc.)      
heavy manual work (e.g. farmer,  
forestry, etc.)       
7. Smoking  
7.4. DO YOU SMOKE:  
yes, every day    
sometimes     
no, never smoked    
smoked previously    
8. Alcohol  
8.1. DO YOU DRINK ALCOHOLIC  
BEVERAGES:  
yes   no   
We provide an explanation of the term 
ALCOHOL UNIT. One alcohol unit 
corresponds to (illustration in Russian 
questionnaire):  
1 bottle (0.33 l) of strong beer or 2 bottles 
(0.33 l) of light beer  
1 ordinary glass of table wine (120 ml)  
1 glass fortified wine (80 ml)  
1 shot of liquor (40%, 40 ml)  
This means that for instance, 0.5 l strong 
beer or 1 l light beer = 1.5 alc. units; 1 
bottle of table wine = 5 alc. units; 1 bottle 
of fortified wine = 8 alc. units; 1 bottle of 
liquor = 15 alc. units.  
8.2. HOW MANY ALC. UNITS DO  
YOU DRINK PER WEEK:  
beer      
table wine     
fortified wine     
liquor      
in total     
 
 
8.5. DO YOU EVER HAVE THOUGHTS  
ABOUT THE NECESSITY TO GIVE  
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UP DRINKING ALCOHOL:  
yes   no    
8.6. DOES CRITICISM OF YOUR  
DRINKING FROM THE SUR-  
ROUNDINGS EVER BOTHER YOU:  
yes   no   
8.7. DO YOU EVER HAVE WORRIES  
OR A SENSE OF GUILT  
REGARDING YOUR DRINKING:  
yes   no   
8.8. DOES IT EVER HAPPEN IN THE  
MORNINGS THAT YOU FIRST OF  
ALL START DRINKING IN ORDER  
TO CALM DOWN OR GET RID OF  
A HANGOVER:  
yes   no   
8.9. HOW OFTEN DO YOU DRINK  
ALCOHOLIC BEVERAGES:  
never         
once a month or less      
2-4 times a month      
2-3 times a week      
4 or more times a week    
8.10. HOW MANY ALC. UN. DO YOU  
USUALLY DRINK ON ONE OCCASION:  
1-2               
3-4               
5-6               
7-9               
10 or more alc. units    
8.11. HOW OFTEN DO YOU DRINK 6 OR  
MORE ALC. UN. ON ONE OCCASION:  
never        
less than once a month    
once a month       
once a week       
daily or almost daily         
8.12. HOW OFTEN DURING THE LAST  
YEAR DID YOU FEEL THAT YOU  
COULD NOT STOP DRINKING  
ONCE YOU HAVE STARTED:  
never        
less than once a month    
once a month       
once a week       
daily or almost daily      
 
8.13. HOW OFTEN DURING THE 
LAST  
YEAR SHOULD YOU HAVE FULFIL-  
LED OR DONE SOMETHING, WHICH  
YOU WERE NOT ABLE TO DO BE-  
CAUSE OF ALCOHOLCONSUMPTION:  
never        
less than once a month    
once a month       
once a week       
daily or almost daily      
8.14. HOW OFTEN DURING THE LAST  
YEAR DID YOU HAVE TO DRINK AL-  
COHOL IN THE MORNING IN ORDER  
TO COME ROUND AFTER HEAVY AL-  
COHOL INTAKE THE DAY BEFORE:  
never       
less than once a month    
once a month      
once a week      
daily or almost daily     
8.15. HOW OFTEN DURING THE LAST  
YEAR WERE YOU UNABLE TO RE-  
CALL WHAT HAPPENED IN THE  
EVENING OF THE DAY BEFORE BE-  
CAUSE OF ALCOHOL 
CONSUMPTION:  
never       
less than once a month    
once a month      
once a week      
daily or almost daily     
8.16. HAVE YOU OR ANYBODY ELSE  
EVER HAD TRAUMA AS A RESULT  
OF YOUR ALCOHOL CONSUMPTION:  
no       
yes, but not in this year    
yes, in this year     
8.17. HAVE ANY OF YOUR RELATIVES,  
FRIENDS OR PERSONS IN THE  
HEALTH SERVICE EVER EXPRES-  
SED ANXIETY REGARDING YOUR  
HARD DRINKING AND SUGGESTED  
THAT YOU BETTER CUT DOWN  
THE ALCOHOL CONSUMPTION:  
no       
yes, but not in this year    
yes, in this year     
 
 
8.18. HOW OFTEN DURING THE LAST  
YEAR HAVE YOU FELT GUILT  
BECAUSE OF YOUR DRINKING:  
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never       
less than once a month    
once a month      
once a week      
daily or almost daily     
THIS PART WILL BE FILLED IN BY 
MED. PERSONELL  
10. Anthropometry  
10.1. WEIGHT:   kg  
10.2. HEIGHT:   cm 
10.5. SYSTOLIC BLOOD PRESSURE:  
1  2  3 
10.6. DIASTOLIC BLOOD 
PRESSURE:  
1  2  3 
10.7. PULSE RATE:  
1  2  3 
11. Laboratory parameters  
11.2. CHOLESTEROL  
11.3. HIGH-DENSITY  
LIPOPROTEIN  




Know Your Heart: Questionnaires 
 (only those questions included in the thesis are listed) 
 
Baseline Questionnaire 
Module A: Socio-demographic Factors 
   
A1. How old are you?             Years 
 97 Difficult to answer 
 98 Refuse to answer 
A3. Interviewer: Please mark the 
gender of the respondent. 
1 Male 
 2 Female 
A9. What is your level of education? 
SHOW CARD 1.  
Please choose the single most 
appropriate answer. 
1 Incomplete secondary or lower  
 
 2 Complete secondary 
 3 Professional school (without secondary 
degree, PTU) 
 4 Professional school and secondary (e.g. PTU 
and secondary education) 
 5 Specialised secondary (e.g. medical, 
pedagogical college, technicum) 
 6 Incomplete higher 
 7 Higher 
 97 Difficult to answer 
 98 Refuse to answer 
A12. Are you in regular paid work? 1 Yes 
 2 No Go to A 14 
 97 Difficult to answer 
 98 Refuse to answer 
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A14. Are you…Ask only those who 
are not in regular paid work (A12-
NO) 
1 In irregular paid work 
 2 Unemployed, seeking work 
 3 Unemployed, not seeking work 
 4 Housewife 
 5 Other 
 5a Other. Specify: 
 6 None of the above 
 97 Difficult to answer 
 98 Refuse to answer 
Module B: Physical Activity 
Next questions will be related to your physical activity. 
 
We would like to know the type and amount of physical activity involved in your work  
(only asked those who worked in the past 12 months) 
 
B1. Please choose what best corresponds 
to your present activities from the following 
four  
possibilities. SHOW CARD 3. 
1 Sedentary occupation - You spend most 
of your time sitting (such as in an office) 
 2 Standing occupation - You spend most 
of your time standing or walking. 
However, your work does not require 
intense physical effort (e.g. shop 
assistant, hairdresser,guard, etc.) 
 3 Physical work - This involves some 
physical effort including handling of 
heavy objects and use  
of tools (e.g. plumber, cleaner, nurse, 
sports instructor, electrician, 
carpenter, etc.) 
 4 Heavy manual work - This involves 
very vigorous physical activity including 
handling of very  
heavy objects (e.g. docker, miner, 
bricklayer, construction worker, etc.) 
 97 Difficult to answer 
 98 Refuse to answer 
Module D: Use of Health Care Services 
This module contains questions about use of medical services, presence of some diseases 
and use of medications. 
D10. Have you ever been told by a doctor (been diagnosed) that you have: 
Arterial hypertension (high blood 




97: Difficult to answer 
98: Refuse to answer 
High cholesterol level     1: Yes 
2: No 
97: Difficult to answer 
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98: Refuse to answer 
Myocardial Infarction/Heart attack  1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Heart failure 1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Atrial fibrillation 1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Angina 1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Stroke 1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Diabetes 1: Yes 
2: No 
97: Difficult to answer 
98: Refuse to answer 
Module G: Alcohol Consumption 
G1-5: For each type of drink listed in the left hand column, please indicate how often each 
was usually drunk in the last 12 months. SHOW CRAD 6. 
G1. Any alcohol 1. Every day or more often 
2. Nearly every day 
3. 3-4 times per week 
4. Once or twice a week 
5. 1-3 times a month 
6. A few times a year 
7. Never or almost never 
97. Difficult to answer 
98. Refuse to answer 
G2: Beer 1. Every day or more often 
2. Nearly every day 
3. 3-4 times per week 
4. Once or twice a week 
5. 1-3 times a month 
6. A few times a year 
7. Never or almost never 
97. Difficult to answer 
      98. Refuse to answer 
G3: Wine (not home produced) 1. Every day or more often 
2. Nearly every day 
3. 3-4 times per week 
4. Once or twice a week 
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5. 1-3 times a month 
6. A few times a year 
7. Never or almost never 
97. Difficult to answer 
      98. Refuse to answer 
G4: Fortified wine (e.g. port wine) 1. Every day or more often 
2. Nearly every day 
3. 3-4 times per week 
4. Once or twice a week 
5. 1-3 times a month 
6. A few times a year 
7. Never or almost never 
97. Difficult to answer 
      98. Refuse to answer 
G5: Spirits (vodka, cognac, whisky, gin, 
rum, etc.) 
1. Every day or more often 
2. Nearly every day 
3. 3-4 times per week 
4. Once or twice a week 
5. 1-3 times a month 
6. A few times a year 
7. Never or almost never 
97. Difficult to answer 
      98. Refuse to answer 
CAGE Score 
G11. During last 12 months how much 
beer did you usually drink on one 
occasion? (‘occasion’ means a single 
continuous period of drinking). Please 
choose the single most appropriate 
answer. 
1. Never drink beer 
2. 1 bottle (0.5l) or less 
3. 2-4 bottles 
4. 5-6 bottles 
5. More than 6 bottles 
97. Difficult to answer 
98. Refuse to answer 
G12. During last 12 months how much 
wine did you usually drink on one 
occasion? Please choose the single most 
appropriate answer. 
1. Never drink wine 
2. Up to 200g 
3. Between 200-400g 
4. Between 400-600g 
5. Between 600-1000g 
6. More than 1L 
97. Difficult to answer 
      98. Refuse to answer 
G13. During last 12 months how much 
spirits, such as vodka or other spirits, do 
you usually drink on one occasion? Please 
choose the single most appropriate 
answer. 
1. Never drink spirits 
2. Up to 50g 
3. Between 50-100g 
4. Between 100-200g 
5. Between 200-300g 
6. Between 300-400g 
7. Between 400-500g 
8. More than 500g 
97. Difficult to answer 
      98. Refuse to answer 
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G14. During last 12 months what was the 
maximum quantity of beer ever drunk on 
one occasion? Please choose the single 
most appropriate answer. 
1. Never drink beer 
2. 1 bottle (0.5l) or less 
3. 2-4 bottles 
4. 5-6 bottles 
5. More than 6 bottles 
97. Difficult to answer 
      98. Refuse to answer 
Module H: Smoking 
H1. Are you a current smoker? Please 
choose most appropriate answer. 
1. Never smoked 
2. No, ex-smoker 
3. Yes, a current-smoker 
97. Difficult to answer 
98. Refused to answer 
Health Examination Questionnaire 
Alcohol Use Disorder Identification Test  
Systolic & Diastolic BPs 
Resting Heart Rate 
BMI 
Total, HDL- and LDL- cholesterol 
GGT 
   
 
 
  
